Article Text

Download PDFPDF
Suprascapular nerve block reduced chronic shoulder pain and disability in degenerative disease or rheumatoid arthritis

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

 Q In patients with chronic shoulder pain from degenerative disease or rheumatoid arthritis, is suprascapular nerve block (SNB) effective for reducing the resulting pain and disability?

Clinical impact ratings GP/FP/Primary care ★★★★★☆☆ Rheumatology ★★★★★★☆


Embedded ImageDesign:

randomised placebo controlled trial.

Embedded ImageAllocation:


Embedded ImageBlinding:

patients and outcome assessors.*

Embedded ImageFollow up period:

12 weeks.

Embedded ImageSetting:

St Vincent’s University Hospital in Dublin, Ireland and the Repatriation Hospital in Adelaide, South Australia.

Embedded ImagePatients:

83 unselected patients (108 shoulders) (mean age 73 y, 52% men) with chronic shoulder pain of ⩾3 months’ duration resulting from degenerative disease (43 patients, 56 shoulders) or rheumatoid arthritis (40 patients, 52 shoulders). Exclusion criteria included a known allergy …

View Full Text


  • * See glossary.

  • For correspondence: Dr M Shanahan, Repatriation General Hospital, Daw Park, South Australia, Australia.

  • Sources of funding: National Health and Medical Research Council of Australia and the Arthritis Foundation of Australia.

Linked Articles

  • Glossary
    BMJ Publishing Group Ltd